How Does A Long-Pulse 755 Nm Alexandrite Laser Perform In Treating Leg Telangiectasias? Best Outcomes In Lighter Skin Types

A long-pulse 755 nm Alexandrite laser can substantially improve leg telangiectasias, particularly deeper blue or violaceous vessels approximately 0.4–3.0 mm in diameter. Clinical evidence reports up to a 63% reduction after three sessions, with outcomes often improved when laser treatment is combined with appropriately timed sclerotherapy. It is generally best suited to Fitzpatrick Skin Types I–III, where melanin-related epidermal injury is less likely.

The 755 nm Alexandrite laser is a useful option for deeper or medium-sized leg vessels that may respond poorly to more superficial wavelengths. Its principal limitation is melanin absorption, making careful patient selection, cooling, and conservative treatment planning essential.

How the Laser Treats Leg Telangiectasias

Deep vascular targeting

The 755 nm wavelength penetrates approximately 2–3 mm into the skin, allowing it to reach vessels deeper than those readily treated with some shorter visible wavelengths.

This makes it particularly relevant for deeper telangiectasias, venulectasias, and reticular veins, including vessels that appear blue or violaceous.

Selective photothermolysis

The laser delivers a long pulse designed to heat blood within the target vessel while limiting thermal injury to surrounding tissue.

Its vascular effect is related to absorption by hemoglobin, with a useful relative advantage for some deeper, venous-appearing lesions. The treatment endpoint may include vessel coagulation, thrombus formation, and subsequent fibrosis over the days following treatment.

Vessel size matters

The strongest clinical rationale is for vessels measuring approximately 0.4–3.0 mm in diameter.

Very fine vessels below about 0.4 mm may respond poorly because they contain less target chromophore and can be difficult to heat selectively. Vessel depth, color, flow, and the presence of underlying venous disease also affect the result.

Expected Clinical Performance

Improvement usually requires multiple sessions

A single treatment should not be expected to clear all leg telangiectasias. Clinical studies have reported up to 63% reduction after three sessions, although individual results vary.

Treatment intervals and the number of sessions depend on vessel characteristics, treatment response, healing, and whether another modality is being used.

Combination with sclerotherapy

Laser treatment can be particularly useful when vessels are deeper, resistant, or not ideal for injection alone.

Clinical outcomes may improve when sclerotherapy is added, often as part of a staged treatment plan. However, the appropriate sequence and timing should be determined by the treating clinician after assessing the vessel anatomy and possible venous reflux.

Comparison with shorter wavelengths

Compared with shorter visible wavelengths in the approximately 532–600 nm range, 755 nm generally provides deeper penetration and can better reach deeper-seated vessels.

That advantage does not mean it is universally superior. Shorter wavelengths may remain useful for selected superficial, smaller, or more visibly red vessels, while the Alexandrite laser is more compelling when depth is a major concern.

Which Skin Types Are Best Suited?

Fitzpatrick Types I–III

The best candidates are generally patients with Fitzpatrick Skin Types I, II, or III, particularly when the skin is not recently tanned.

These skin types provide a wider safety margin for delivering effective vascular energy because there is less competing melanin absorption in the epidermis.

Why darker skin requires more caution

Although 755 nm can penetrate deeply, it is also absorbed by melanin. That creates a risk of post-inflammatory hyperpigmentation, hypopigmentation, or epidermal thermal injury, especially in darker or recently tanned skin.

Patients with Types IV–VI are not automatically excluded, but the risk–benefit balance is less favorable. An experienced clinician may consider alternative wavelengths, lower-risk protocols, test spots, or other treatments depending on the vessel and skin characteristics.

Skin assessment should go beyond the phototype number

Recent sun exposure, tanning, baseline pigmentation, medications, prior pigmentary reactions, and the location of the vessels all influence safety.

A patient with Fitzpatrick Type III skin and a tan may carry more risk than an untanned patient with the same nominal classification.

Treatment Parameters That Influence Safety and Efficacy

Pulse duration and fluence must match the vessel

Effective selective photothermolysis requires pulse duration and energy to be matched to the target vessel’s thermal behavior.

For selected vessels in Types I–III, published treatment approaches include short pulse durations under 10 milliseconds and relatively high fluences, sometimes in the range of 50–80 J/cm². These figures are not universal prescriptions; device design, spot size, vessel depth, skin type, and cooling all require individualized adjustment.

Cooling protects the epidermis

Dynamic or active epidermal cooling is an important safety measure, particularly when higher fluences are used.

Cooling helps reduce epidermal heating and may lower the risk of dyspigmentation, but it does not eliminate the risk. Appropriate clinical endpoints and avoidance of excessive treatment remain essential.

Technique affects the outcome

Practitioners should generally use contiguous, non-overlapping pulses and avoid unnecessary pulse stacking.

Overlapping or repeatedly treating the same area can increase thermal injury without proportionally improving vessel clearance.

Understanding the Trade-offs

The treatment is not ideal for every vessel

The Alexandrite laser is less predictable for extremely fine vessels, and it may not address the underlying cause of widespread leg telangiectasias.

If venous reflux or larger feeder veins are present, treating only the visible surface vessels may produce incomplete or temporary improvement.

Pigmentary complications are possible

The key limitation is the wavelength’s interaction with melanin. Even when treatment is technically appropriate, patients may experience temporary redness, swelling, crusting, or pigmentary change.

The risk increases with darker or tanned skin, excessive fluence, inadequate cooling, and aggressive treatment of overlapping areas.

Sclerotherapy may still be preferable

Sclerotherapy remains an important alternative or adjunct, particularly for suitable reticular veins and vessels that are difficult to treat effectively with light-based therapy.

The best approach is often determined by vessel diameter, depth, color, flow, underlying venous anatomy, skin type, and patient preference—not by the laser wavelength alone.

Making the Right Choice for Your Goal

The most appropriate treatment plan should follow a vascular assessment rather than relying on vessel appearance alone.

If your primary focus is treating deeper or violaceous leg vessels: A long-pulse 755 nm Alexandrite laser is a reasonable option, especially for vessels approximately 0.4–3.0 mm in diameter.
If your primary focus is maximizing clearance: Discuss a staged or combined plan involving Alexandrite laser treatment and sclerotherapy when clinically appropriate.
If your primary focus is minimizing pigmentary risk: The treatment is most favorable in untanned Fitzpatrick Types I–III, with active cooling, test spots, and carefully selected parameters.
If your primary focus is treating very fine vessels or darker skin: Ask whether another wavelength or modality offers a safer and more predictable risk–benefit profile.

Used with appropriate patient selection and technique, the 755 nm Alexandrite laser is a valuable tool for deeper leg telangiectasias—but its success depends as much on vessel and skin assessment as on the device itself.

Summary Table:

Parameter	Details
Wavelength	755 nm
Target Vessel Size	0.4–3.0 mm diameter, deeper blue/violaceous veins
Penetration Depth	2–3 mm
Best Skin Types	Fitzpatrick I–III (untanned)
Typical Improvement	Up to 63% after 3 sessions
Combination	May be combined with sclerotherapy for better results
Main Risk	Pigmentary changes, especially in darker skin
Parameters	Pulse duration <10 ms, fluence 50–80 J/cm² (example)
Cooling	Essential to protect epidermis

Discover how BELIS's advanced 755 nm Alexandrite laser systems can elevate your clinic's vascular treatments. Our professional-grade devices are designed for optimal safety and efficacy in Fitzpatrick I–III skin types. Contact us today to learn more about our laser solutions and how they can benefit your practice. Get in touch now!

Menu

How does a long-pulse 755 nm Alexandrite laser perform in treating leg telangiectasias? Best outcomes in lighter skin types